VYNE Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 2.95 M | $1.92 M | 177.28% | 137.95% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 2.00 M | $1.30 M | 0.00% | 93.53% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 1.63 M | $1.06 M | 0.00% | 76.16% |
| SHAY CAPITAL LLC | 08/14/2026 | 1.46 M | $947.84 K | -9.54% | 68.12% |
| T3 COMPANIES, LLC | 07/27/2026 | 945.00 K | $614.91 K | 0.00% | 44.19% |
| BRAIDWELL LP | 08/14/2026 | 916.08 K | $596.09 K | 0.00% | 42.84% |
| KVP CAPITAL ADVISORS, LP | 08/13/2026 | 500.55 K | $325.71 K | 0.00% | 23.41% |
| CITADEL ADVISORS LLC | 09/02/2026 | 468.46 K | $304.83 K | -8.94% | 21.91% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 438.82 K | $285.54 K | 2.91% | 20.52% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 381.80 K | $248.00 K | 0.00% | 17.85% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 264.91 K | $172.38 K | 0.00% | 12.39% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 264.56 K | $172.23 K | 0.00% | 12.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 258.20 K | $168.02 K | -19.99% | 12.07% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 183.44 K | $119.42 K | 0.00% | 8.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 118.96 K | $77.41 K | 105.86% | 5.56% |
| RANGELEY CAPITAL, LLC | 08/14/2026 | 113.06 K | $73.57 K | -4.24% | 5.29% |
| XTX TOPCO LTD | 08/14/2026 | 78.72 K | $51.22 K | -50.30% | 3.68% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 71.53 K | $47.00 K | 100.00% | 3.35% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2026 | 61.27 K | $39.87 K | 100.00% | 2.87% |
| UBS GROUP AG | 08/13/2026 | 58.60 K | $38.15 K | -67.41% | 2.74% |
| BLACKROCK, INC. | 08/07/2026 | 44.41 K | $28.90 K | 0.00% | 2.08% |
| NORTHERN TRUST CORP | 08/13/2026 | 43.68 K | $28.42 K | 89.00% | 2.04% |
| JANE STREET GROUP, LLC | 08/14/2026 | 40.97 K | $26.66 K | -57.16% | 1.92% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 40.70 K | $26.48 K | 100.00% | 1.90% |
| FNY INVESTMENT ADVISERS, LLC | 07/08/2026 | 35.00 K | $22.00 K | 0.00% | 1.64% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 23.30 K | $15.16 K | 34.68% | 1.09% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/29/2026 | 18.30 K | $11.91 K | 0.00% | 0.86% |
| STATE STREET CORP | 08/07/2026 | 15.77 K | $10.26 K | 0.00% | 0.74% |
| ANSON FUNDS MANAGEMENT LP | 08/13/2026 | 14.46 K | $9.41 K | -98.84% | 0.68% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 12.99 K | $8.46 K | 268.42% | 0.61% |
| HARVEST INVESTMENT SERVICES, LLC | 08/14/2026 | 11.06 K | $7.20 K | 0.00% | 0.52% |
| ACORN CAPITAL ADVISORS, LLC | 08/14/2026 | 1.43 K | $926 | 0.00% | 0.07% |
| MB, LEVIS & ASSOCIATES, LLC | 07/22/2026 | 1.04 K | $677 | 0.00% | 0.05% |
| HURLEY CAPITAL, LLC | 08/10/2026 | 561 | $365 | 0.00% | 0.03% |
| BARCLAYS PLC | 08/14/2026 | 141 | $92 | 100.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 65 | $42 | 0.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 43 | $28 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 08/12/2026 | 25 | $16 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 08/14/2026 | 10 | $7 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 8 | $5 | -94.52% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 08/14/2026 | 2 | $1 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 1 | $1 | 100.00% | 0.00% |
| FLAGSHIP WEALTH ADVISORS, LLC | 07/27/2026 | 1 | $1 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VYNE Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 58 institutional investors and hedge funds held shares of VYNE Therapeutics Inc. The most heavily invested institutionals were:
ADAR1 Capital Management, LLC: 2.95 M
Nantahala Capital Management, LLC: 2 M
Lynx1 Capital Management LP: 1.63 M
Shay Capital LLC: 1.46 M
T3 Companies, LLC: 945,000
BRAIDWELL LP: 916,077
629.59% of VYNE Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 16.11 M shares in the last 24 months. This purchase volume represents approximately $9.50 M in transactions.